BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18543336)

  • 1. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis.
    Ohta Y; Kamiya T; Nagai M; Nagata T; Morimoto N; Miyazaki K; Murakami T; Kurata T; Takehisa Y; Ikeda Y; Asoh S; Ohta S; Abe K
    J Neurosci Res; 2008 Oct; 86(13):3028-37. PubMed ID: 18543336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
    Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
    Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
    Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
    Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
    Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice.
    Chian RJ; Li J; Ay I; Celia SA; Kashi BB; Tamrazian E; Matthews JC; Bronson RT; Rossomando A; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2009 Sep; 1287():1-19. PubMed ID: 19563785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.
    Ryu H; Smith K; Camelo SI; Carreras I; Lee J; Iglesias AH; Dangond F; Cormier KA; Cudkowicz ME; Brown RH; Ferrante RJ
    J Neurochem; 2005 Jun; 93(5):1087-98. PubMed ID: 15934930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
    Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
    Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene therapy and neurotrophic factor treatment for amyotrophic lateral sclerosis].
    Abe K; Manabe Y; Murakami T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1160-1. PubMed ID: 12235826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway.
    González de Aguilar JL; Gordon JW; René F; de Tapia M; Lutz-Bucher B; Gaiddon C; Loeffler JP
    Neurobiol Dis; 2000 Aug; 7(4):406-15. PubMed ID: 10964611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy.
    Tsai LK; Tsai MS; Ting CH; Wang SH; Li H
    Neurobiol Dis; 2008 Sep; 31(3):361-7. PubMed ID: 18590823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
    Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
    Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
    Calingasan NY; Chen J; Kiaei M; Beal MF
    Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
    Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
    Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
    Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
    Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
    Gomes C; Keller S; Altevogt P; Costa J
    Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis.
    Nagano I; Ilieva H; Shiote M; Murakami T; Yokoyama M; Shoji M; Abe K
    J Neurol Sci; 2005 Aug; 235(1-2):61-8. PubMed ID: 15990113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide.
    Taghibiglou C; Lu J; Mackenzie IR; Wang YT; Cashman NR
    Biochem Biophys Res Commun; 2011 Sep; 413(2):159-63. PubMed ID: 21871872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective adeno-associated virus Bcl-xL gene transfer in models of motor neuron disease.
    Garrity-Moses ME; Teng Q; Liu J; Tanase D; Boulis NM
    Muscle Nerve; 2005 Dec; 32(6):734-44. PubMed ID: 16116646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.